Clinical and genetic study of a juvenile-onset Huntington disease

Chinese Journal of Contemporary Neurology and Neurosurgery

Volumn 12, Issue 3, 2012, Pages 288-293

  Hao, Ying ^a   Chen, Yuan Yuan ^a   Gu, Wei Hong ^a   Wang, Guo Xiang ^a   Ma, Hui Zi ^b   Li, Li Lin ^b   Wang, Kang ^a   Jin, Miao ^a   Duan, Xiao Hui ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Adolescent; Huntington disease; Nucleotides; Polymorphism, genetic; Repetitive sequences, nucleic acid

Indexed keywords

MEMBRANE PROTEIN; PROTEIN IT15; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CAG REPEAT; CAPILLARY ELECTROPHORESIS; CLONE; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUNTINGTON CHOREA; HYPOKINESIA; INHERITANCE; JUVENILE ONSET HUNTINGTON DISEASE; MAJOR CLINICAL STUDY; MALE; PATERNAL INHERITANCE; POLYMERASE CHAIN REACTION; RIGIDITY;

EID: 84869752961     PISSN: 16726731     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-6731.2012.03.011     Document Type: Article

References (18)

1. Ciarmiello A, Giovacchini G, Orobello S, et al. (18)F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size. Eur J Nucl Mol Imaging, 2012, 39: 1030-1036.
2. Roos RA. Huntington's disease: a clinical review. Orphanet J Rare Dis, 2010, 5: 40.
3. Langdahl BL, Carstens M, Stenkjaer L, et al. Polymorphisms in the transforming growth factor beta 1 gene and osteoporosis. Bone, 2003, 32: 297-310.
4. Johri A, Beal MF. Antioxidants in Huntington's disease. Biochim Biophys Acta, 2012, 1822: 664-674.
5. Ramaswamy S, Kordower JH. Gene therapy for Huntington's disease. Neurobiol Dis, 2011. [Epub ahead of print]
6. Lin MT, Gan SR, Chen WJ, et al. Gene analysis of two families with Huntington disease. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2008, 8: 124-128.
7. Liu ZG, Wang WA. Clinical characteristics and progress in treatment of Huntington disease. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2007, 7: 25-28.
8. Hunter JM, Crouse AB, Lesort M, et al. Verification of somatic CAG repeat expansion by pre-PCR fractionation. J Neurosci Methods, 2005, 144: 11-17.
9. Yan YP, Zhang BR. The molecular mechanisms of Huntington's disease and its advances in therapeutic strategies. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2011, 11: 30-35.
10. Zheng Z, Burgunder JM, Shang H, et al. Huntington's like conditions in China, a review of published Chinese cases. Plos Curr, 2012, 4: RRN1302.
11. Orr HT, Zoghbi HY. Trinucleotide repeat disorders. Annu Rev Neurosci, 2007, 30: 575-621.
12. Smith MA, Brandt J, Shadmehr R. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature, 2000, 403: 544-549.
13. Sturrock A, Leavitt BR. The clinical and genetic features of Huntington disease. J Geriatr Psychiatry Neurol, 2010, 23: 243-259.
14. Reyes Molón L, Yáñez Sáez RM, López-lbor Alcocer MI. Juvenile Huntington's disease: a case report and literature review. Actas Esp Psiquiatr, 2010, 38: 285-294.
15. Nance MA, Myers RH. Juvenile onset Huntington's disease-clinical and research perspectives. Ment Retard Dev Disabil Res Rev, 2001, 7: 153-157.
16. Walker FO. Huntington's disease. Lancet, 2007, 369: 218-228.
17. Ribai P, Nguyen K, Hahn-Barma V, et al. Psychiatric and cognitive difficulties as indicators of juvenile Huntington disease onset in 29 patients. Arch Neurol, 2007, 64: 813-819.
18. Yoon G, Kramer J, Zanko A, et al. Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology, 2006, 67: 1265-1267.